An innovative urinary drainage system that could reduce NHS CAUTI treatment costs by 10% and increase quality-of-life for men suffering from chronic incontinence

％20创新％20泌尿％20引流％20系统％20％20可以％20减少％20NHS％20CAUTI％20治疗％20成本％20by％2010％％20和％20增加％20生活质量％20为％20男性％20痛苦％20来自％20慢性％20失禁

• 批准号: 10094849
• 金额: $ 23.3万
• 依托单位: INGENION MEDICAL LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10094849
• 关键词: innovative; urinary; drainage; system; could

Ingenion is a UK-based medical device SME with a core project team of Edward Cappabianca (project lead), Susan Finch (project manager), James Barnett (design engineer), Tim Maloney (commercial director) and Zia Mursaleen (finance manager).Urinary incontinence impacts physical and emotional health, causing humiliation and social issues. Frequent catheterisation increases the risk of catheter-associated urinary tract infections (CAUTIs), which can be fatal and cost the NHS £567.6M/year. CAUTIs represent 17.2% of all Health-Care Associated Infections (HCAIs), and HCAIs have been estimated to cost the NHS between £1.6-£5B/year (Canadian-Journal-of -Infection-Control,Sep2020). Long-term catheter users experience an average of 2.7 CAUTIs per year (Coloplast, 2023), with a cost of £3,500 per incident. Around 90,000 people in the UK live with long-term catheters, with over 4B catheters used worldwide annually. Some people try to manage incontinence by drinking less water, but this has been shown to worsen apparently unrelated conditions, such as dementia.To solve this unmet need, Ingenion is developing a revolutionary indwelling urinary drainage system (_**cym**active_ SealSoft) that eliminates the need for external bags or tubes. The _**cym**active_ SealSoft device for incontinence will provide male patients with normal fill/void cycles without any inconvenience or risk of CAUTIs.This innovation will have a significant impact on patients suffering from MS, Parkinson's, spinal cord injuries and spina bifida. Not only will it improve their quality of life, but it will also help increase their life expectancy by allowing them to remain active. The unique selling points of this device are its leak-proof design and patented magnetic valve technology, which ensures greater confidence and a potential economic benefit from a reduction in CAUTI treatment costs for the NHS by 10% of the HCAIs related to CAUTIs could be as much as £57M/year.

Ingenion是一家总部位于英国的医疗设备中小企业，由Edward Cappabianca（项目负责人），Susan Finch（项目经理），James Barnett（设计工程师），Tim Maloney（商业总监）和Zia Mursaleen（财务经理）。尿道失禁影响身体健康和情感健康，引起仇恨和社会问题的影响。频繁的导管插入增加了与导管相关的尿路感染（CAUTIS）的风险，这可能是致命的，并且每年耗资5.676亿英镑。 CAUTIS占所有相关感染（HCAI）的17.2％，据估计，HCAI估计占NHS的费用在每年1.6至5B英镑之间（加拿大 - 感染控制，Sep2020）。长期导管使用者平均每年2.7 cautis（Coloplast，2023），每次事件的成本为3500英镑。英国约有90,000人与长期导管生活，每年在全球使用超过4B导管。有些人试图通过少喝水来管理尿失禁，但事实证明这显然是无关的疾病，例如痴呆症。为了解决这种未满足的需求，Ingenion正在开发一种革命性的留置尿引流系统（_ ** cym ** active_ active_ sealsoft），从而消除了对外部袋或管的需求。 _ ** cym ** Active_ sealsoft设备用于失禁，将为男性患者提供正常的填充/空隙周期，而不会给您带来任何不便或cautis风险。这项创新将对患有MS，帕金森氏症，脊髓损伤和脊柱裂的患者产生重大影响。它不仅可以改善他们的生活质量，而且还可以通过允许他们保持活跃来帮助提高预期寿命。该设备的独特销售点是其防泄漏设计和专利的磁性阀技术，这确保了较高的信心和潜在的经济利益，因为NHS的CAUTI治疗成本降低了与CATIS相关的HCAIS的10％，每年可能高达5700万英镑。